These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 12494139)

  • 1. [Lipoprotein (a) and ischemic heart disease in patients with hypertensive disease].
    Britareva VV; Afanas'eva OI; Dobrovol'skiĭ AB; Titaeva EV; Karpov IuA; Pokrovskiĭ SN
    Kardiologiia; 2002; 42(5):4-8. PubMed ID: 12494139
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of serum total homocysteine with the extent of ischemic heart disease in a Mediterranean cohort.
    Vrentzos G; Papadakis JA; Malliaraki N; Zacharis EA; Katsogridakis K; Margioris AN; Vardas PE; Ganotakis ES
    Angiology; 2004; 55(5):517-24. PubMed ID: 15378114
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Importance of lipoprotein(a) in patients with ischemic heart disease].
    Nakamura Y; Yokoi Y; Hamaguchi H; Toyonaga T; Kondo T; Takami S; Kubo M; Matsuzawa Y
    J Cardiol; 1992; 22(2-3):319-23. PubMed ID: 1339790
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A four-year prospective study on the influence of serum elevated lipoprotein (a) concentration on ischemic heart disease and cerebral infarction in elderly patients with type 2 diabetes].
    Suzuki T; Oba K; Igari Y; Matsumura N; Inuzuka Y; Kigawa Y; Ajiro Y; Okazaki K; Nakano H; Metori S
    Nihon Ronen Igakkai Zasshi; 2001 Jul; 38(4):507-13. PubMed ID: 11523163
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Apolipoprotein B100 as a risk factor of acute coronary syndrome and this risk factor effect on arterial hypertension in patients with ischemic heart disease].
    Arabidze GG; Pokrovskiĭ SN; Afanas'eva MI; Tebloev KI; Memetov KA; Skriabina EO
    Ter Arkh; 2005; 77(9):35-9. PubMed ID: 16281487
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Elevated levels of lipoprotein(a) are present in subjects with early ischemic cardiopathy and with a familial history of ischemic cardiopathy].
    Saitta A; Castaldo M; Sardo A; Cinquegrani M; Bonaiuto M; Zema M; Gravina M; Mangano C
    Minerva Med; 1999; 90(5-6):151-8. PubMed ID: 10780189
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High levels of serum lipoprotein(a) in patients with ischemic heart disease with normal coronary angiogram and thromboangiitis obliterans.
    Takami S; Kubo M; Yamashita S; Kameda-Takemura K; Kawasaki T; Kanbayashi J; Nakamura Y; Yokoi Y; Ohnishi K; Matsuzawa Y
    Atherosclerosis; 1995 Jan; 112(2):253-60. PubMed ID: 7772084
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Differences and similarities in ischemic heart disease in men and women].
    Piwowarska W; Zylińska M
    Folia Med Cracov; 1991; 32(1-2):43-56. PubMed ID: 1843699
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between electrocardiographic ischemic abnormalities and ischemic heart disease risk factors in a Japanese population.
    Choudhury SR; Yoshida Y; Kita Y; Nozaki A
    J Hum Hypertens; 1996 Apr; 10(4):225-34. PubMed ID: 8736453
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nonfasting triglycerides and risk of myocardial infarction, ischemic heart disease, and death in men and women.
    Nordestgaard BG; Benn M; Schnohr P; Tybjaerg-Hansen A
    JAMA; 2007 Jul; 298(3):299-308. PubMed ID: 17635890
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The role of atherosclerosis risk factors in development of ischemic heart disease in young men].
    Ezhov MV; Afanas'eva OI; Kambegova AA; Afanas'eva MI; Trukhacheva EP; Naumov VG; Pokrovskiĭ SN
    Ter Arkh; 2009; 81(5):50-4. PubMed ID: 19537587
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pentanucleotide repeat polymorphism, lipoprotein(a) levels, and risk of ischemic heart disease.
    Kamstrup PR; Tybjaerg-Hansen A; Steffensen R; Nordestgaard BG
    J Clin Endocrinol Metab; 2008 Oct; 93(10):3769-76. PubMed ID: 18682504
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma fibronectin levels in ischemic heart disease.
    Song KS; Kim HK; Shim W; Jee SH
    Atherosclerosis; 2001 Feb; 154(2):449-53. PubMed ID: 11166778
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipoprotein(a): fasting and nonfasting levels, inflammation, and cardiovascular risk.
    Langsted A; Kamstrup PR; Nordestgaard BG
    Atherosclerosis; 2014 May; 234(1):95-101. PubMed ID: 24632508
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extreme lipoprotein(a) levels and risk of myocardial infarction in the general population: the Copenhagen City Heart Study.
    Kamstrup PR; Benn M; Tybjaerg-Hansen A; Nordestgaard BG
    Circulation; 2008 Jan; 117(2):176-84. PubMed ID: 18086931
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contribution of Lp(a) to the occurrence of vascular diseases: correlation of several risk factors including diabetes mellitus.
    Kubo M; Takami S; Matsuzawa Y
    J Atheroscler Thromb; 1995; 2 Suppl 1():S22-5. PubMed ID: 9225226
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antihypertensive treatment, high triglycerides, and low high-density lipoprotein cholesterol and risk of ischemic heart disease mortality: a 16-year follow-up in the Copenhagen male study.
    Suadicani P; Hein HO; Gyntelberg F
    Metab Syndr Relat Disord; 2010 Jun; 8(3):215-22. PubMed ID: 20156073
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimal high-density lipoprotein cholesterol cutoff for predicting cardiovascular disease: Comparison of the Korean and US National Health and Nutrition Examination Surveys.
    Moon JH; Koo BK; Moon MK
    J Clin Lipidol; 2015; 9(3):334-42. PubMed ID: 26073391
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Association of lipoprotein(a) and apolipoprotein(a) phenotypes with coronary and carotid atherosclerosis in CHD men].
    Ezhov MV; Afanas'eva OI; Benevolenskaia GF; Savchenko AP; Balakhonova TV; Liakishev AA; Pokrovskiĭ SN
    Ter Arkh; 2000; 72(1):28-32. PubMed ID: 10687202
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lipoprotein(a) was an independent predictor for major coronary events in treated hypertensive men.
    Agewall S; Fagerberg B
    Clin Cardiol; 2002 Jun; 25(6):287-90. PubMed ID: 12058792
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.